Two-Drug attack tested for Tough-to-Treat bladder cancer
Disease control
Terminated
This early-phase study tested a combination of two drugs, selinexor and pembrolizumab, for patients with advanced bladder cancer who could not receive or did not respond to standard chemotherapy. The goal was to find a safe dose and see if the combination could shrink tumors. The…
Phase: PHASE1, PHASE2 • Sponsor: Mamta Parikh • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC